The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study

Rituximab is used to eliminate B cells as a chimeric monoclonal antibody directed against CD20, a B-cell antigen expressed on B cells. To explore the impact of rituximab administered before transplantation, we implemented a retrospective, monocentric study and utilized real-world data collected at o...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Xiya Wei, Yiyu Xie, Ruoyu Jiang, Huiyu Li, Heqing Wu, Yuqi Zhang, Ling Li, Shiyuan Zhou, Xiao Ma, Zaixiang Tang, Jun He, Depei Wu, Xiaojin Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Subjects:	rituximab B cell prior to transplantation allogeneic hematopoietic stem cell transplantation EBV - Epstein-Barr virus aGVHD: acute graft vs host disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.967026/full